In vitro activity of the histatin derivative P-113 against multidrug-resistant pathogens responsible for pneumonia in immunocompromised patients.

In vitro activity of the histatin derivative P-113 against multidrug-resistant pathogens responsible for pneumonia in immunocompromised patients.

Item
http://www.wikidata.org/entity/Q33857777
The P-113 fragment of histatin 5 requires a specific peptide sequence for intracellular translocation in Candida albicans, which is independent of cell wall binding.Resistance of Porphyromonas gingivalis ATCC 33277 to direct killing by antimicrobial peptides is protease independentHydrophilic/hydrophobic characters of antimicrobial peptides derived from animals and their effects on multidrug resistant clinical isolates.Histatin 5-spermidine conjugates have enhanced fungicidal activity and efficacy as a topical therapeutic for oral candidiasis.Antibacterial Peptides: Opportunities for the Prevention and Treatment of Dental Caries.Activity of short lipopeptides and conventional antimicrobials against planktonic cells and biofilms formed by clinical strains of Staphylococcus aureus.Human Salivary Protein Histatin 5 Has Potent Bactericidal Activity against ESKAPE Pathogens.Histatin-derived monomeric and dimeric synthetic peptides show strong bactericidal activity towards multidrug-resistant Staphylococcus aureus in vivoIn vitro activity of aurein 1.2 alone and in combination with antibiotics against gram-positive nosocomial cocci.Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain.In vitro activity and killing effect of uperin 3.6 against gram-positive cocci isolated from immunocompromised patients.Specific Histidine Residues Confer Histatin Peptides with Copper-Dependent Activity against Candida albicans.
P2860

In vitro activity of the histatin derivative P-113 against multidrug-resistant pathogens responsible for pneumonia in immunocompromised patients.

Item
http://www.wikidata.org/entity/Q33857777
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
In vitro activity of the hista ...... in immunocompromised patients.
@ast
In vitro activity of the hista ...... in immunocompromised patients.
@en
type
label
In vitro activity of the hista ...... in immunocompromised patients.
@ast
In vitro activity of the hista ...... in immunocompromised patients.
@en
prefLabel
In vitro activity of the hista ...... in immunocompromised patients.
@ast
In vitro activity of the hista ...... in immunocompromised patients.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P932
P356
P1433
P1476
In vitro activity of the hista ...... in immunocompromised patients.
@en
P2093
P2860
P304
P31
P356
10.1128/AAC.49.3.1249-1252.2005
P407
P433
P478
P577
P698
P921
P932